激活蛋白C的PAR1裂变的结构决定因素
Bosko M Stojanovski1, Enrico Di Cera1
1Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.
研究人员设计了激活蛋白C (APC),以提高其对蛋白酶激活受体1 (PAR1) 的特异性. 这种修改通过改变APC的关键结构部分来改善细胞保护功能.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 蛋白质溶解是一种蛋白质溶解.
背景情况:
- 活性蛋白C (APC) 通过蛋白酶激活受体1 (PAR1) 裂变具有细胞保护功能,但特异性较低.
- 凝血素也分裂PAR1,但具有高特异性,独立于EPCR,并引起促炎反应.
- 在PAR1上APC和血栓的不同特异性的结构基础是未知的.
研究的目的:
- 阐明管理APC对PAR1的特异性的结构性决定因素.
- 了解APC的结构变化如何影响PAR1裂变点的选择.
主要方法:
- 通过结合血栓的PAR1识别决定因素来设计APC.
- 具体的修改包括将T99替换为Leucine,并将37和60循环的APC与来自血栓的循环交换.
主要成果:
- 工程APC变种对PAR1.1的特异性增加了80倍.
- 在R41的裂痕增强了,而在R46的裂痕在工程变体中减少了.
- 变种APC60/T99L和APC37/60/T99L表现出对Va因子的活性显著降低.
结论:
- 37-,60-和99-段的APC是其细胞保护性和抗凝固性质的关键决定因素.
- 结构修改可以精确调整APC的酶特异性和功能.
- 了解这些结构功能关系对于开发有针对性的基于APC的治疗方法至关重要.
更多相关视频
08:56Demonstration of Proteolytic Activation of the Epithelial Sodium Channel ENaC by Combining Current Measurements with Detection of Cleavage Fragments
Published on: July 5, 2014
07:53A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
相关概念视频
Caspases
Complement System
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Intracellular Signaling Affects Focal Adhesions
Some...
Amplifying Signals via Enzymatic Cascade
